Clinical trial
Montelukast for Early Life Wheezing
NCT00115297 · University of Massachusetts, Worcester, Other · Completed
Key facts
| NCT number | NCT00115297 |
|---|---|
| Title | Montelukast for Early Life Wheezing |
| Official title | Effects of Montelukast on Early Life Wheezing |
| Lead sponsor | University of Massachusetts, Worcester, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Lung Diseases, Asthma |
| Intervention type | Drug |
| Interventions | Montelukast, Placebo |
| Enrollment | 62 |
| Start date | Sep 1, 2004 |
| Primary completion | Oct 1, 2016 |
| Completion | Oct 1, 2016 |
| First posted | Jun 22, 2005 |
| Last update posted | Mar 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: